Cargando…
Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review
BACKGROUND: Recent decades have seen combination chemoradiotherapy become the standard treatment for anal squamous cell carcinoma (SCC). However, the burden of this disease continues to rise, with only 10% of patients with metastatic disease surviving >2 years. Further insight into tumour charact...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008609/ https://www.ncbi.nlm.nih.gov/pubmed/21063399 http://dx.doi.org/10.1038/sj.bjc.6605984 |
_version_ | 1782194525570072576 |
---|---|
author | Lampejo, T Kavanagh, D Clark, J Goldin, R Osborn, M Ziprin, P Cleator, S |
author_facet | Lampejo, T Kavanagh, D Clark, J Goldin, R Osborn, M Ziprin, P Cleator, S |
author_sort | Lampejo, T |
collection | PubMed |
description | BACKGROUND: Recent decades have seen combination chemoradiotherapy become the standard treatment for anal squamous cell carcinoma (SCC). However, the burden of this disease continues to rise, with only 10% of patients with metastatic disease surviving >2 years. Further insight into tumour characteristics and molecular biology may identify novel therapeutic targets. This systematic review examines current prognostic markers in SCC of the anus. METHODS: An extensive literature search was performed to identify studies reporting on biomarkers in anal cancer in the context of clinical outcome following treatment primarily with chemoradiotherapy. RESULTS: In all, 21 studies were included. A total of 29 biomarkers were studied belonging to 9 different functional classes. Of these biomarkers, 13 were found to have an association with outcome in at least one study. The tumour-suppressor genes p53 and p21 were the only markers shown to be of prognostic value in more than one study. CONCLUSIONS: An array of biomarkers have been identified that correlate with survival following chemoradiotherapy in anal cancer. However, investigators are yet to identify a biomarker that has the ability to consistently predict outcome in this disease. Further studies are needed to elucidate whether these candidate biomarkers demonstrate their optimum value when they serve as targets for new therapeutic strategies. |
format | Text |
id | pubmed-3008609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-30086092011-12-07 Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review Lampejo, T Kavanagh, D Clark, J Goldin, R Osborn, M Ziprin, P Cleator, S Br J Cancer Molecular Diagnostics BACKGROUND: Recent decades have seen combination chemoradiotherapy become the standard treatment for anal squamous cell carcinoma (SCC). However, the burden of this disease continues to rise, with only 10% of patients with metastatic disease surviving >2 years. Further insight into tumour characteristics and molecular biology may identify novel therapeutic targets. This systematic review examines current prognostic markers in SCC of the anus. METHODS: An extensive literature search was performed to identify studies reporting on biomarkers in anal cancer in the context of clinical outcome following treatment primarily with chemoradiotherapy. RESULTS: In all, 21 studies were included. A total of 29 biomarkers were studied belonging to 9 different functional classes. Of these biomarkers, 13 were found to have an association with outcome in at least one study. The tumour-suppressor genes p53 and p21 were the only markers shown to be of prognostic value in more than one study. CONCLUSIONS: An array of biomarkers have been identified that correlate with survival following chemoradiotherapy in anal cancer. However, investigators are yet to identify a biomarker that has the ability to consistently predict outcome in this disease. Further studies are needed to elucidate whether these candidate biomarkers demonstrate their optimum value when they serve as targets for new therapeutic strategies. Nature Publishing Group 2010-12-07 2010-11-09 /pmc/articles/PMC3008609/ /pubmed/21063399 http://dx.doi.org/10.1038/sj.bjc.6605984 Text en Copyright © 2010 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Molecular Diagnostics Lampejo, T Kavanagh, D Clark, J Goldin, R Osborn, M Ziprin, P Cleator, S Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review |
title | Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review |
title_full | Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review |
title_fullStr | Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review |
title_full_unstemmed | Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review |
title_short | Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review |
title_sort | prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review |
topic | Molecular Diagnostics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008609/ https://www.ncbi.nlm.nih.gov/pubmed/21063399 http://dx.doi.org/10.1038/sj.bjc.6605984 |
work_keys_str_mv | AT lampejot prognosticbiomarkersinsquamouscellcarcinomaoftheanusasystematicreview AT kavanaghd prognosticbiomarkersinsquamouscellcarcinomaoftheanusasystematicreview AT clarkj prognosticbiomarkersinsquamouscellcarcinomaoftheanusasystematicreview AT goldinr prognosticbiomarkersinsquamouscellcarcinomaoftheanusasystematicreview AT osbornm prognosticbiomarkersinsquamouscellcarcinomaoftheanusasystematicreview AT ziprinp prognosticbiomarkersinsquamouscellcarcinomaoftheanusasystematicreview AT cleators prognosticbiomarkersinsquamouscellcarcinomaoftheanusasystematicreview |